Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.

Screening baseline is good but voluntary. Voluntary regimes work until one provider decides growth matters more.

Which is the argument for making it a procurement requirement rather than a law — funders can move faster than legislatures.

True, and said so in the README. The Rust part was mostly so contributors stop segfaulting the pH loop.

We got a term sheet last year that explicitly cut the CMC budget to make the burn look better. Declined.

Rewriting firmware in Rust is fun but the actual reliability win here was the watchdog, which you could have added in C.